Study This 12 page paper is based in the case study provided by the student. Genesis research and development Corporation have been in existence for many years, but to fail to make a profit. The position of the company is examined with the use of a PEST and SWOT analysis, including consideration of the financial results. The way in which they the influences may be impacting on the valuation of the companies discussed, and the paper make suggestions to the new CEO on strategies it should be undertaken to protect long-term interests of the company. The paper ends with a Porters five forces analysis. The bibliography cites 3 sources.
Name of Research Paper File: TS14_TEgenesis.rtf
Buy This Research Paper »
Unformatted Sample Text from the Research Paper:
useful in examining the company and its existing position. PEST Analysis Political influences are highly relevant within the biotechnology industries in New Zealand. At first glance it appears that
there is a high level of support, for biotechnology industries from the New Zealand government. In response to previous criticisms the government had launched a NZ$100 million venture investment fund
to help fund high technology startups, working with the private sector and other venture capital investors. Further to this additional funding has been announced, with the aim of an injection
of $16.8 million directed at the biotechnology sector to take place between 2003 and 2007. This appears to indicate that there is a high level of this will support for
the biotechnology industry with in New Zealand. Especially when it is considered in the context of other sporting activities, such as the provision of $1.3 million to create an amalgamated
industry body called New Zealand Bio, and the fact that by October 2004 the New Zealand government had invested total $70 million on local biotechnology companies.
The strong connections with Australia are likely to be beneficial, especially as Australia seen as the leading biotechnology country with in the South Pacific region. This
is especially true for firms such as Genesis who have a core strategy of strategic alliances, work with other companies in order to overcome the companies own limitations. However, there
are some specific areas in place that help to make New Zealand a difficult place to undertake biotechnology research due to the high level of regulation which is present within
the country. However, despite the apparent high level of investment, compared to many other countries the actual investment may be seen as relatively constrained.
Back to Research Paper Results